NDC 51672-1264-01 - Fluocinonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1264
- Requested NDC
- 51672-1264-01
- Package NDCs from labels
- 51672-1264-1, 51672-1264-2, 51672-1264-3, 51672-1264-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-04-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluocinonide - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-04-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Fluocinonide - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-12-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1264-1 | Fluocinonide | 1 in 1 CARTON | OINTMENT | 1 | 8 | |
| 51672-1264-1 | Fluocinonide | 15 g in 1 TUBE | OINTMENT | 15 | 8 | |
| 51672-1264-2 | Fluocinonide | 30 g in 1 TUBE | OINTMENT | 30 | 8 | |
| 51672-1264-2 | Fluocinonide | 1 in 1 CARTON | OINTMENT | 1 | 8 | |
| 51672-1264-3 | Fluocinonide | 60 g in 1 TUBE | OINTMENT | 60 | 8 | |
| 51672-1264-3 | Fluocinonide | 1 in 1 CARTON | OINTMENT | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1264 | FLUOCINONIDE CREAM FLUOCINONIDE GEL FLUOCINONIDE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20240823_b0bc89a9-c9d5-4adb-9785-2d4487c4c656.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1264-1 | GM - Gram | 51672-1264 | 958b2b2c-971f-4fde-8565-4476717f7475 | 1 | 2012-07-24 |
| 51672-1264-2 | GM - Gram | 51672-1264 | d8600fc2-2cc4-40a6-aec7-25b1f6d042da | 1 | 2012-07-24 |
| 51672-1264-3 | GM - Gram | 51672-1264 | 7790c8f0-c982-4e43-b534-ca531e38b357 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Advanced Healing | PETROLATUM | Rite Aid Corporation | 0d535736-ba61-42eb-9112-c154295372a2 | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 2968PHW8QP |
| UNIVERSAL BABY FRESH SCENT PETROLEUM | WHITE PETROLEUM | Universal Distribution Center LLC | ec67a1ee-ad71-54f2-e053-2995a90a7690 | 2026-01-29 | Warnings | 4T6H12BN9U |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Petroleum | WHITE PETROLATUM | 7-Select | 7e93df71-74bd-4d95-9a64-54756c7b234a | 2026-01-29 | Warnings, Adverse reactions | 4T6H12BN9U |
| TheraCare Diabetic Foot Cream | DIMETHICONE, PETROLATUM | Veridian Healthcare | 49132a75-4a16-cede-e063-6294a90a6217 | 2026-01-29 | Warnings | 4T6H12BN9U |
| TheraCare A and D | LANOLIN, PETROLATUM | Veridian Healthcare | 1303aa33-2111-b36c-e063-6294a90af131 | 2026-01-29 | Warnings | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Aldi, Inc | 94fea2f2-fea8-4923-afc6-36068bc2fef5 | 2026-01-29 | Warnings, Adverse reactions | 4T6H12BN9U |
| UNIVERSAL LAVENDER SCENT PETROLEUM | WHITE PETROLEUM | Universal Distribution Center LLC | 066b1313-aed8-9436-e063-6294a90a2b11 | 2026-01-29 | Warnings | 4T6H12BN9U |
| Mineral Oil | MINERAL OIL | CARDINAL HEALTH 110, LLC. DBA LEADER | 803f444f-d136-4f06-9842-24a71a3d7d6b | 2026-01-29 | Warnings, Adverse reactions | T5L8T28FGP |
| careone hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | American Sales Company | 46794d2e-8fe6-490d-9cfa-ba9b6c209ad6 | 2026-01-29 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | XF417D3PSL |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| fluocinonide | FLUOCINONIDE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | ebca0c66-06f6-438a-a01a-634c53debc06 | 2026-01-28 | Adverse reactions | 2W4A77YPAN |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | GLENMARK THERAPEUTICS INC., USA | 5aba6bb1-d25d-4901-8e9c-4cd4a3a06471 | 2026-01-27 | Warnings | G2M7P15E5P |
| VERADEX-E | PETROLATUM AND LANOLIN | ABBE Laboratories, Inc. | 00100102-c245-4b63-a4ff-794cacda6f17 | 2026-01-24 | Warnings | 4T6H12BN9U |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals Inc. | 935f05da-3637-4a9e-843e-1f2ced5d1a74 | 2026-01-23 | Warnings | G2M7P15E5P |
| foster and thrive hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | 9da843f2-e88c-432e-b091-a6acf81d856b | 2026-01-22 | Warnings | 4T6H12BN9U T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.